Drug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany. Hormosan Pharma GmbH, a wholly-owned subsidiary of the company in Germany, has introduced Luforbec in the European nation, Lupin said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M6rQV5Y
via IFTTT
0 comments:
Post a Comment